XMD 8-92 (CAS 1234480-50-2): R&D Systems
Catalog Number: 4132
Chemical Name: 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
Biological Activity
ERK5 (BMK1) and BRD4 inhibitor (Kd values are 80 and 190 nM, respectively). Also inhibits DCAMKL2, PLK4 and TNK1 (Kd values are 190, 600 and 890 nM). Blocks growth factor-induced activation of cellular BMK1 and reduces BMK1 activity in in vitro kinase assays. Also reduces BMK1-dependent transactivating activity of MEF2C. Inhibits proliferation in a variety of cancer cell lines; blocks tumor cell proliferation and tumor-associated angiogenesis.
External Portal Information
Chemicalprobes.org is a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of XMD 8-92 is reviewed on the chemical probes website.
Technical Data
  • M.Wt:
    474.55
  • Formula:
    C26H30N6O3
  • Solubility:
    Soluble to 40 mM in DMSO
  • Purity:
    >98%
  • Storage:
    Store at RT
  • CAS No:
    1234480-50-2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis. All Tocris products are intended for laboratory research use only.
Additional Information
Licensing Caveats:
Sold under license from the Dana-Farber Cancer Institute.
Background References
  1. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.
    Yang et al.
    Cancer Cell, 2010;18:258
  2. Targeting the BMK1 MAP kinase pathway in cancer therapy.
    Yang and Lee
    Clin.Cancer Res., 2011;17:3527
  3. Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a potent and selective inhibitor of big MAP kinase 1.
    Deng et al.
    ACS Med.Chem.Lett., 2011;2:195
  4. Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.
    Erazo et al.
    Mol.Cell Biol., 2013;33:1671
  5. ERK5 kinase activity is dispensable for cellular immune response and proliferation.
    Lin et al.
    Proc.Natl.Acad.Sci.U.S.A., 2016;113:11865
Citations:

The citations listed below are publications that use Tocris products. Selected citations for XMD 8-92 include:

2 Citations: Showing 1 - 2
Filter your results:

  1. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.
    Authors: Simões Et al.
    Cell Death Dis 2015;6:e1718
  2. Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.
    Authors: Al-Ejeh Et al.
    Mediators Inflamm 2014;5:3145

Have you used XMD 8-92?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.

Order Details

Note:

Contact Information

Calculators

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

R&D Systems Guarantee

or select another batch: 

Feedback

Customer Information